News
📈 Stocks
AstraZeneca Shares Drop on Report of Mega-Merger Talks With Bristol Myers
(50 days ago)
AstraZeneca shares fell on news of preliminary merger talks with Bristol Myers, sparking investor concerns over deal execution and antitrust risks.